Project title: Developing heparan sulfate glycan array
This proposal is aimed at developing a high throughput method to study the interactions between heparan
sulfate (HS) and proteins. HS is a highly sulfated polysaccharide displaying a wide range of biological
functions. Glycan Therapeutics is a company specialized in HS related research products. In this proposal, an
HS array technique will be constructed using both a microtiter plate format and a microarray format. The
strength of the company is the capability of synthesizing structurally defined HS oligosaccharides using the
chemoenzymatic method, allowing the synthesis of HS oligosaccharide in gram scale. This synthetic capability
will ensure access to the oligosaccharide substrates at low cost and allows Glycan Therapeutics to have full
control over the purity of the substrates. This unique strength will enable Glycan Therapeutics to produce high
quality HS microtiter plates and HS micro-array chips at an affordable price. Aim 1 is designed to prepare HS
microtiter plates based HS array. The major advantage of HS microtiter plate is that they are reusable and
convenient. No additional equipment other than a microplate reader is needed. Furthermore, this method can
be expanded to investigate the roles of HS in cell-based functional assays. Aim 2 is to prepare HS microarray
technique. This technique will allow screening a very large number of HS oligosaccharides and proteins using
very small amounts of carbohydrate and protein samples. The HS microarray technology will be readily
integrated with existing carbohydrate-array methods in a centralized facility specialized in carbohydrate
screening.
In phase I studies, a library of 60 HS oligosaccharides will be affixed on a microtiter plate or on a microarray
slide for biological screening. The HS microtiter plates or array slides will be tested thoroughly to ensure
quality. In the phase II studies, the number of oligosaccharides on the microtiter plates and array slides will be
expanded to 200 to fully represent the structures of HS isolated from natural sources. Success will lead to a
convenient and reliable approach for improving research in glycosciences.
Public Health Relevance Statement
Project Narrative
Heparan sulfates are highly important polysaccharides that interact with different proteins to regulate human
physiology. In this project, Glycan Therapeutics plans to develop an innovative tool to study the binding
selectivity of heparan sulfate and proteins. The success of the project will advance glycosciences in the
research community.
NIH Spending Category
No NIH Spending Category available.
Project Terms
AntibodiesBacterial InfectionsBindingBiologicalBiological AssayBiological ProcessBlood coagulationBudgetsCarbohydratesCellsCommunitiesCustomEmbryonic DevelopmentEnsureEquipmentExtracellular MatrixHeparitin SulfateHumanImmobilizationInflammatory ResponseLabelLettersLibrariesLicensingMethodsMicroarray AnalysisMonitorNorth CarolinaOligosaccharidesPhysiologicalPhysiologyPlayPolysaccharidesPositioning AttributePreparationPriceProcessProteinsReaderResearchResearch SupportRoleSamplingServicesShipsSlideSmall Business Technology Transfer ResearchSourceStructureStructure-Activity RelationshipSurfaceSystemTechniquesTechnologyTestingTherapeuticTissuesUnited States National Institutes of HealthUniversitiesUnspecified or Sulfate Ion SulfatesValidationViralbasecostcost effectivedesignhigh throughput screeningimprovedinnovationinterestmilligramnew technologyphase 1 studyphase 2 studyresponsescreeningsuccesstool
No Sub Projects information available for 5R41GM123792-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R41GM123792-02
Patents
No Patents information available for 5R41GM123792-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R41GM123792-02
Clinical Studies
No Clinical Studies information available for 5R41GM123792-02
News and More
Related News Releases
No news release information available for 5R41GM123792-02
History
No Historical information available for 5R41GM123792-02
Similar Projects
No Similar Projects information available for 5R41GM123792-02